Skip to main content

Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome

This is a preview of subscription content, access via your institution.

References

  1. Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S (2014) Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol. doi:10.1007/s00467-014-2765-z

    Google Scholar 

  2. Hirano D, Fujinaga S, Nishizaki N (2012) The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome. Clin Nephrol 77:510–512

    CAS  PubMed  Article  Google Scholar 

  3. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S (2010) Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatr Nephrol 25:957–959

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuichiro Fujinaga.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fujinaga, S., Hara, T. Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome. Pediatr Nephrol 29, 1291–1292 (2014). https://doi.org/10.1007/s00467-014-2800-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-014-2800-0

Keywords

  • Complete Remission
  • Mycophenolate Mofetil
  • Pneumococcal Meningitis
  • Methylprednisolone Pulse Therapy
  • Generalize Edema